Loading...
Home 2017-12-19T20:14:34+00:00

Our MISSION is to improve the way value is measured and rewarded in the healthcare system.
Our GOAL is to promote the development and use of high value interventions that advance health.

The Value Debate

Scientific, technological, and clinical advances are driving a revolution in patient care – but spending on health care also continues to increase. Most observers agree that change is needed in order to link health care spending to value rather than volume, but determining how to make this link quickly leads to debate and disagreement. What defines value? Value to whom? And how do we measure it?

A New Approach

The Innovation and Value Initiative (IVI) was created to raise the level of discussion regarding value in health care and find common ground in the approach to measuring value. The U.S health system is diverse, complex, and ripe for innovation. IVI brings together health care leaders from academia, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and patient communities to advance approaches to value that fit the American context.

Patients are likely to continue to be asked to take more responsibility for their healthcare…it is time to shift the discussion toward helping patients understand what value actually means in choosing their health care and discharging their financial responsibilities.

Alan Balch and Darius Lakdawalla, Writing on the Health Affairs Blog

Learn More

Latest News

IVI was founded in the belief that an informed and dispassionate dialogue around value assessment is essential to the future vitality of the American health care system. Through our research and publications, we are leveraging evidence and influencing the national dialogue about value.

Connect with us on social media to keep the conversation going.

Well-Informed Patients Play a Key Role in Value-Based Care

January 12th, 2018|

In a commentary for Morning Consult, Virginia Ladd, President and Executive Director of the American Autoimmune Related Diseases Association (AARDA), emphasizes how critical it is that the patient perspective be front and center in discussions [...]

Putting More Value Into Biopharmaceutical Value Assessments

January 4th, 2018|

In a commentary for the Health Affairs Blog, Rena M. Conti, PhD, and IVI Executive Director, Darius Lakdawalla, argue that advancing the science of value assessment requires new assessment tools that are transparent and incorporate [...]

An Open-Source Consensus-Based Approach to Value Assessment

December 15th, 2017|

In a commentary for the Health Affairs Blog, IVI's Jeroen Jansen, Devin Incerti, and Mark Linthicum argue that, in order to move toward consensus on value assessment, the process for defining and measuring value must be [...]